Market Watch – Page 559 – Biotech Insider

All Posts in "Market Watch"

Gold futures settle lower, then rally past $1,450 as Trump threatens new tariffs on Chinese goods

Palladium, platinum suffer sharp declines too

by Editor — August 02, 2019 By Editor in Market Watch

Shopify stock rockets higher after earnings; COO sees growing recognition of company’s breadth

Company exceeded expectations with third-quarter forecast and raised outlook for the full year

by Editor — August 02, 2019 By Editor in Market Watch

GoPro stock swings to gains after promising second-half rebound

After earnings miss sent shares down more than 7% in after-hours trading, raised forecast sends stock to gains of almost 5%

by Editor — August 02, 2019 By Editor in Market Watch

Dow ends 280 points lower as Trump announces additional tariffs on China

The 10% levies would apply to $300 billion of U.S. imports from China from Sept. 1

by Editor — August 02, 2019 By Editor in Market Watch

Twilio shares tumble despite stellar quarter

CEO cites Fed rate cut for after-hours loss; ‘We had a great quarter’

by Editor — August 01, 2019 By Editor in Market Watch

Fitbit stock falls after Versa Lite disappointment prompts lowered outlook

CEO says company misjudged pricing, go-to-market strategy

by Editor — August 01, 2019 By Editor in Market Watch

Qualcomm stock falls as Huawei business stripped from outlook

Qualcomm sees up to $5.1 billion in revenue, while analysts expect $5.67 billion

by Editor — August 01, 2019 By Editor in Market Watch

GE stock swings back to gains in wake of earnings and free cash flow beats, raised outlook

CFO departure, rising costs of 737 Max grounding act as brief distractions

by Editor — August 01, 2019 By Editor in Market Watch

Tesla’s margins are ‘more solid than they appear,’ this analyst says

Macquarie keeps $400 price target on Tesla

by Editor — July 31, 2019 By Editor in Market Watch

Electronic Arts stock rises after revenue tops consensus estimates

Videogame company gets boost from income-tax benefits

by Editor — July 31, 2019 By Editor in Market Watch

Nothing in this publication should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. Biotech Insider is a wholly-owned subsidiary of Market IQ Media Group, Inc.

While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.